Aims and Scope
Journal of Investigative Medicine (JIM) is the official publication of the American Federation for Medical Research. The journal is peer-reviewed and publishes high-quality original articles and reviews in the areas of basic, clinical, and translational medical research.
JIM publishes on all topics and specialty areas that are critical to the conduct of the entire spectrum of biomedical research: From the translation of clinical observations at the bedside, to basic and animal research to clinical research and the implementation of innovative medical care.
The journal aims to provide rapid publication of research through its continuous online publication model. Submissions should be made through the journal’s new online submission system. Articles should not be under review or under consideration by any other journal when submitted to JIM.
JIM is a member journal of the Committee on Publication Ethics (COPE) and is a sponsor of the Equator Network, which is an international initiative that promotes transparent, accurate reporting of research studies.
American Federation for Medical Research members enjoy free access to JIM as part of their member benefits. Members can login here.
Journal Statistics
|
Frequency |
8 issues / year |
|
Impact Factor |
1.943 |
|
Indexed by |
Index Medicus (Medline), ISI Current Contents (Web of Science), Science Citation Index, Google Scholar, PubMed, Scopus |
|
Launch date |
1995 |
|
ISSN |
1081-5589 (print) 1708-8267 (online) |
To advertise
Information on rates and how to advertise in JIM
General advertising information for BMJ
Affiliations
Established in 1940, the American Federation for Medical Research is an international multi-disciplinary association of scientists engaged in all areas of biomedical investigation-patient-oriented, translational, and basic research. www.afmr.org/. Members login here.
Dryad is an international repository of data underlying peer-reviewed articles in the basic and applied biosciences. Dryad enables scientists to validate published findings, explore new analysis methodologies, repurpose data for research questions unanticipated by the original authors, and perform synthetic studies. BMJ has been working with Dryad since 2010.
The BMJ is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.
The mission of OASPA is to support and represent the interests of open access journal publishers globally in all scientific, technical, and scholarly disciplines. BMJ has been a member since 2009.
Open Access articles in Journal of Investigative Medicine are licensed using either Creative Commons Attribution (CC BY) or Attribution Non-Commercial (CC BY-NC) license. These licenses let others distribute, remix, tweak and build upon your work.
BMJ is a founding organization of the AllTrials initiative, which calls for all past and present clinical trials to be registered and their results reported.